BioCentury
ARTICLE | Finance

Ebb & Flow Sequenom's angels

Sequenom discloses investors behind restart of Down syndrome test

May 31, 2010 7:00 AM UTC

In an SEC filing last week, Sequenom Inc. (NASDAQ:SQNM) disclosed the investors who ponied up the $51.6 million private placement of 12.4 million shares at $4.15 on May 17.

A large group of investors thought the 23% discount was worth the bet: Tang Capital bought 3.3 million shares; Visium (2.8 million shares); Redmile Capital (1.5 million shares); Deerfield Capital (1.3 million shares); Manning & Napier (1.1 million shares); Perceptive Life Sciences (662,700 shares); OrbiMed Advisors (630,000 shares); Ramius (482,000 shares); Palo Alto Investors (301,250); UBS (248,000 shares); Summer Street (130,000 shares); and PW Eucalyptus (16,100 shares)...